Patents
Patents for C07K 19 - Hybrid peptides (29,428)
09/2008
09/18/2008US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine
09/18/2008US20080227699 Therapeutic Agent for Neurodegenerative Diseases
09/18/2008US20080227157 Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album
09/18/2008US20080227129 Using multimeric ubiquitin fusion protein as an enzyme activity indicator; destruction of reporter demonstrate enhanced enzyme activity
09/18/2008US20080226667 Toll-like receptor modulator for use in prevention and treatment of neurodegenerative disorders
09/18/2008US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy
09/18/2008US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer
09/18/2008US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells
09/18/2008CA2680549A1 Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents
09/17/2008EP1970449A1 Attenuated salmonella SPI2 mutants as antigen carriers
09/17/2008EP1970386A2 Hybrid immunoglobulins
09/17/2008EP1969165A1 Methods for generating and screening fusion protein libraries and uses thereof
09/17/2008EP1969005A1 Apoptosis-inducing protein complexes and therapeutic use thereof
09/17/2008EP1141331B1 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
09/17/2008EP1066328B1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
09/17/2008CN101268102A Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI) -anchors for treatment of cancer and skin lesions
09/17/2008CN101265482A Recombination tumor chalone-tumor putrescence factor secretion type eukaryon expression vector and its preparation method and use
09/17/2008CN101265300A Small molecule recombination toxin GnRH-luffinS2 fusion albumen and its preparation and application
09/17/2008CN100419068C Yeast stain for preparing Pres-E1-E2 vaccine of hepatitis B and hepatitis C virus and preparation method thereof
09/17/2008CN100418985C Cleavage of fusion proteins using granzyme b protease
09/17/2008CN100418983C Human pancreas hyperglycemiacin relative peptide-2 analogue
09/17/2008CN100418981C Gene differentially expressed in breast and bladder cancer and encoded polypeptides
09/16/2008US7425335 Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus
09/16/2008US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal
09/16/2008US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies
09/16/2008CA2409748C Soluble ctla4 mutant molecules and uses thereof
09/16/2008CA2252799C Antiviral ricin-like proteins
09/16/2008CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods
09/16/2008CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
09/12/2008WO2008089569A9 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
09/12/2008WO2008054881A9 Antibacterial and plasmid elimination agents
09/12/2008WO2007059298B1 Chimeric immunoreceptor useful in treating human cancers
09/12/2008CA2679765A1 T4 bacteriophage bound to a substrate
09/12/2008CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins
09/11/2008US20080221303 Coupling N- alpha -o-nitrophenyl sulphenyl (N- alpha -Nps)-protected amino acid with nucleotides
09/11/2008US20080221020 Dendrimers as Molecular Translocators
09/11/2008US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types
09/11/2008US20080221011 CR2-FH C-reactive protein, factor H fusion protein; inhibiting complement activation of the alternative pathway
09/11/2008US20080220451 T1r2 binding assays
09/11/2008US20080220002 Modified transferin-antibody fusion proteins
09/11/2008US20080219999 Immunoadhesin for the prevention of rhinovirus infection
09/11/2008US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/11/2008US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer
09/11/2008US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer
09/11/2008US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders
09/11/2008US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer
09/10/2008EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer
09/10/2008EP1967206A2 Anti-IgE vaccines
09/10/2008EP1967205A2 Anti-IgE vaccines
09/10/2008EP1966246A2 Methods and compositions for needleless delivery of antibodies
09/10/2008EP1966244A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
09/10/2008EP1442134B1 Method for producing and identifying soluble protein domains
09/10/2008EP1200124B1 Erythropoietin-immunoglobulin fusion proteins
09/10/2008CN101260157A Fusion polypeptide and application thereof in preparing antineoplastic, antiviral and intracellular bacterial parasite infection curing medicament
09/10/2008CN101260149A Streptococcus antigens
09/10/2008CN101260148A Hybrid and tandem expression of neisserial proteins
09/10/2008CN101260145A Technique for separating and purifying recombination human serum albumin and fusion protein thereof
09/09/2008US7423120 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
09/09/2008US7423119 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/09/2008US7423023 Enhancement of immune response using targeting molecules
09/09/2008US7423016 Genetic engineering; inducting immunology response
09/09/2008US7422877 Activatable recombinant neurotoxins
09/09/2008US7422849 Hybridizing sample with a nucleic acid molecule to a transcript of gene wherein said transcript is RNA or cDNA; determining hybridization as a determination of expression of gene
09/09/2008US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5
09/09/2008US7422741 VEGFR-3 fusion proteins
09/08/2008CA2621608A1 Methods of optimizing the secretion of protein in prokaryotes
09/04/2008WO2008086634A3 Chimeric umami taste receptor, nucleic acid encoding it and use thereof
09/04/2008US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders
09/04/2008US20080214784 Human t1r2 taste receptor polypeptides
09/04/2008US20080214782 Amino acid sequence phosphorylation site motif; structural variance and disease diagnosis
09/04/2008US20080213886 Albumin fusion proteins
09/04/2008US20080213880 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors
09/04/2008US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level
09/04/2008US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
09/04/2008US20080213272 Vegf-related protein
09/03/2008EP1964854A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
09/03/2008EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
09/03/2008EP1963361A2 Multimeric complexes of antigens and an adjuvant
09/03/2008EP1430083B1 T1r taste receptors and genes encoding same
09/03/2008EP1292613B1 Chimeric GPF-Aequorin as bioluminiscent Ca++ reporters at the single cell level
09/03/2008EP1180159B1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders
09/03/2008EP1161455B1 A novel chimeric protein for prevention and treatment of hiv infection
09/03/2008CN101257927A Peptide conjugate for oral delivery of hydrophilic peptide analgesics
09/03/2008CN101255197A Fusion protein for serum albumin and interleukin 1 receptor antagonist and uses thereof
09/03/2008CN101255193A Preparation of specific antibodies aiming at PCDH10C terminal protein segment molecule
09/03/2008CN101255192A Soluble CTLA4 mutant molecules and uses thereof
09/03/2008CN100415876C Aids recombination gland virus vaccine
09/02/2008US7420047 Nucleotide sequence encoding antigenic peptide; induces immune response which does not cause anaphylaxis when administered; safety
09/02/2008US7420042 Soluble neuropilin/growth factor receptor fusion proteins
09/02/2008US7420037 Heat shock protein-based vaccines and immunotherapies
09/02/2008US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation
09/02/2008US7419780 invention relates to the evolution of enzymes in vivo, and drug screening in vivo through the use of chemical inducers of protein dimerization
09/02/2008US7419676 Activatable recombinant neurotoxins
09/02/2008CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf
09/02/2008CA2306350C Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
09/02/2008CA2303478C Group a streptococcal vaccines
09/02/2008CA2175577C Receptor on the surface of activated t-cells: acts-4
09/02/2008CA2144307C Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
08/2008
08/28/2008WO2008101671A2 Il-4 fc fusion proteins
08/28/2008WO2008101415A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof